APA (7th ed.) Citation

GH, L., PH, T., AR, J., AA, T., WC, S., VB, Y., & GW, Y. (2014). Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. Singapore medical journal, 55(9), 468. https://doi.org/10.11622/smedj.2014115

Chicago Style (17th ed.) Citation

GH, Lim, Tan PH, Jara-Lazaro AR, Thike AA, Sim WC, Yap VB, and Yip GW. "Syndecan-1 Is a Potential Biomarker for Triple-positive Breast Carcinomas in Asian Women with Correlation to Survival." Singapore Medical Journal 55, no. 9 (2014): 468. https://doi.org/10.11622/smedj.2014115.

MLA (9th ed.) Citation

GH, Lim, et al. "Syndecan-1 Is a Potential Biomarker for Triple-positive Breast Carcinomas in Asian Women with Correlation to Survival." Singapore Medical Journal, vol. 55, no. 9, 2014, p. 468, https://doi.org/10.11622/smedj.2014115.